Analysis of delayed core biopsy results during COVID-19 pandemic: the experience of a single public center

Authors

DOI:

https://doi.org/10.29289/2594539420240023

Keywords:

breast neoplasms, core biopsy, descriptive epidemiology, referred pain, menopause, early diagnosis

Abstract

To observe and analyze the waiting time for breast biopsy and the impact of this time on the early diagnosis of breast cancer in Santa Catarina. Methods: Observational cohort study. Data collection was performed through direct observation with the application of a questionnaire and subsequent quantitative analysis. A convenience sample was used, in which data were computed through a questionnaire administered to patients in cases where a breast biopsy with a thick needle was requested due to the existence of a suspicious lesion in the physical examination or in imaging examinations requested as breast cancer screening. Data from the collection instrument were extracted through direct interviews with patients in the office and completion of a questionnaire, after their correct guidance and signing of an informed consent form. The percentage of malignant versus benign lesions and the pain scale during core biopsy were evaluated. Results: The questionnaire was submitted to 71 women who attended the mastology outpatient clinic at the Hospital Regional de São José – Dr. Homero de Miranda Gomes (HRSJ-HMG) between October 2021 and May 2022. Of these, 7 did not undergo breast biopsy due to the lesion not being identified, 39.1% resulted in malignant neoplasia and 60.9% in benign lesion. Regarding the assessment of pain during core biopsy, 57.8% experienced mild or no pain, 21.8% moderate pain and 10.9% severe pain.

Downloads

Download data is not yet available.

References

1. Brasil. Ministério da Saúde. Câncer de mama. Brasília: Ministério da Saúde; 2020 [cited on 2021 Nov 16]. Available from: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/c/cancer-de-mama

2. Brasil. Ministério da Saúde. INCA estima 704 mil casos de câncer por ano no Brasil até 2025. Rio de Janeiro: INCA; 2022 [cited on 2023 July 05]. Available from: https://www.gov.br/inca/pt-br/assuntos/noticias/2022/inca-estima-704-mil-casos-de-cancer-por-ano-no-brasil-ate-2025

3. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018; 391(10125):1023-75. https://doi.org/10.1016/S0140-6736(17)33326-3

4. Brasil. Portal de Boas Práticas em Saúde da Mulher, da Criança e do Adolescente. Estimativa 2018: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2017 Available from: https://portaldeboaspraticas.iff.fiocruz.br/biblioteca/estimativa-2018-incidencia-de-cancer-no-brasil/

5. Demarchi PKH, Maurer E, Pierini NI, Lammel BL, Sirqueira ACV, Maggi LS, et al. O impacto da pandemia da covid-19 no volume de mamografias no brasil: uma análise de previsão baseada nos números históricos. Rev Bras Cancerol. 2022;68(3):e-232566. https://doi.org/10.32635/2176-9745.RBC.2022v68n3.2566

6. Carvalho FM, Kerr LM. Anatomia Patológica e Citologiano rastreamento e diagnóstico das alterações mamárias. Rev Bras Mastologia. 2013;23(2):42-7.

7. Chesebro AL, Chikarmane SA, Ritner JA, Birdwell RL, Giess CS. Troubleshooting to overcome technical challenges in image-guided breast biopsy challenges in image-guided breast biopsy. Radiographics. 2017;37(3):705-18. https://doi.org/10.1148/rg.2017160117

8. Schnitt SJ. Problematic issues in breast core needle biopsies. Mod Pathol. 2019;32(Suppl 1):71-6. https://doi.org/10.1038/s41379-018-0137-0

9. Degnim AC, King TA. Surgical management of high-risk breast lesions. Surg Clin North Am. 2013;93(2):329-40. https://doi.org/10.1016/j.suc.2012.12.005

10. Mooney KL, Bassett LW, Apple SK. Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review. Mod Pathol. 2016; 29(12):1471-84. https://doi.org/10.1038/modpathol.2016.127

11. Garicochea B, Morelle A, Andrighetti AE, Cancella A, Bós A, Werutsky G. Idade como fator prognóstico no câncer de mama em estágio inicial. Rev Saúde Pública. 2009;43(2):311-7. https://doi.org/10.1590/S0034-89102009005000009

12. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7-33. https://doi.org/10.3322/caac.21654

13. Łukasiewicz E, Ziemiecka A, Jakubowski W, Vojinovic J, Bogucevska M, Dobruch-Sobczak K. Fine-needle versus core-needle biopsy – which one to choose in preoperative assessment of focal lesions in the breasts? Literature review. J Ultrason. 2017;17(71):267-74. https://doi.org/10.15557/JoU.2017.0039

14. Balasubramanian I, Fleming CA, Corrigan MA, Redmond HP, Kerin MJ, Lowery AJ. Meta-analysis of the diagnostic accuracy of ultrasound-guided fine-needle aspiration and core needle biopsy in diagnosing axillary lymph node metastasis. Br J Surg. 2018;105(10):1244-53. https://doi.org/10.1002/bjs.10920

Downloads

Published

2025-04-28

How to Cite

Ferrari, M. Ávila, Ronsoni, N. F., Ozol de Ávila, G. A., Cechella, P., Freitas, A., & Heinzen, R. (2025). Analysis of delayed core biopsy results during COVID-19 pandemic: the experience of a single public center. Mastology, 34. https://doi.org/10.29289/2594539420240023

Issue

Section

Original Articles